Combined AlloStim+Anti-PD-L1 in MSS Metastatic Colorectal Cancer
- Conditions
- Metastatic Colorectal Cancer
- First Posted Date
- 2024-08-16
- Last Posted Date
- 2024-08-16
- Lead Sponsor
- Mirror Biologics, Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT06557278
- Locations
- 🇺🇸
New York Cancer and Blood Specialists, Shirley, New York, United States
🇺🇸Mt. Sinai Comprehensive Cancer Center, Miami Beach, Florida, United States
🇺🇸Hirschfield Oncology Center, Brooklyn, New York, United States
Immunotherapy for Advanced Liver Cancer
- Conditions
- Hepatocellular Carcinoma
- Interventions
- First Posted Date
- 2021-09-02
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- Mirror Biologics, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT05033522
- Locations
- 🇲🇾
Sultan Ismail Hospital, Johor Bahru, Johor, Malaysia
🇲🇾Columbia Asia Bukit Rimau, Shah Alam, Selangor Darul Ehsan, Malaysia
🇲🇾Sultanah Bahiyah Hospital, Alor Setar, Kedah, Malaysia
Immunotherapy for Third Line Metastatic Colorectal Cancer
- Conditions
- Metastatic Colorectal Cancer
- Interventions
- Biological: AlloStim
- First Posted Date
- 2020-06-23
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- Mirror Biologics, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT04444622
- Locations
- 🇺🇸
Summit Health, Florham Park, New Jersey, United States
🇺🇸Karmanos Cancer Institute, Detroit, Michigan, United States
🇺🇸Mt. Sinai Comprehensive Cancer Center, Miami Beach, Florida, United States
Universal Anti-Viral Vaccine for Healthy Elderly Adults
- Conditions
- PneumoniaCOVID-19 Respiratory InfectionRSV PneumoniaVirus DiseasesInfluenza, HumanARDS, Human
- Interventions
- Drug: AlloStim
- First Posted Date
- 2020-06-22
- Last Posted Date
- 2023-04-18
- Lead Sponsor
- Mirror Biologics, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT04441047
- Locations
- 🇺🇸
Florida Medical Clinic, LLC, Zephyrhills, Florida, United States
🇺🇸Delray Physician Care Center, Delray Beach, Florida, United States
🇺🇸Model Research, Tampa, Florida, United States
Study Comparing AlloVax™ to Chemotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head & Neck
- Conditions
- Squamous Cell Carcinoma Head and Neck
- Interventions
- Biological: AlloVax™Drug: Cisplatin
- First Posted Date
- 2015-12-09
- Last Posted Date
- 2020-01-22
- Lead Sponsor
- Mirror Biologics, Inc.
- Registration Number
- NCT02624999
- Locations
- 🇹🇭
National Cancer Institute of Thailand, Bangkok, Thailand
An Individualized Anti-Cancer Vaccine in Advanced Hepatocellular Carcinoma Subjects
- Conditions
- Advanced Adult Hepatocellular Carcinoma
- Interventions
- Biological: AlloVaxBiological: AlloStimBiological: CRCL
- First Posted Date
- 2015-04-07
- Last Posted Date
- 2020-01-22
- Lead Sponsor
- Mirror Biologics, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT02409524
- Locations
- 🇹🇭
National Cancer Institute of Thailand Address: 268/1 Rama Rd. Ratchathewi, Bangkok, Thailand
AlloStim® Immunotherapy Dosing Alone or in Combination With Cryoablation in Metastatic Colorectal Cancer
- Conditions
- Colorectal Cancer Metastatic
- Interventions
- Biological: AlloStimProcedure: Cryoablation
- First Posted Date
- 2015-03-05
- Last Posted Date
- 2020-01-22
- Lead Sponsor
- Mirror Biologics, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT02380443
- Locations
- 🇺🇸
Banner MD Anderson Medical Center, Gilbert, Arizona, United States
Increased Frequency of AlloStim(TM) Dosing in Combination With Cryoablation in Metastatic Breast Cancer Patients
- Conditions
- Metastatic Breast Cancer
- Interventions
- Biological: AlloStimProcedure: Cryoablation
- First Posted Date
- 2013-12-23
- Last Posted Date
- 2020-01-22
- Lead Sponsor
- Mirror Biologics, Inc.
- Registration Number
- NCT02018419
- Locations
- 🇺🇸
Medical Oncology Associates of San Diego, San Diego, California, United States
Safety and Tolerability Study of AlloVax(TM) in Patients With Metastatic or Recurrent Cancer of the Head and Neck
- Conditions
- Cancer of Head and NeckSquamous Cell Carcinoma of the Head and Neck
- Interventions
- Biological: AlloVaxBiological: CRCLBiological: AlloStim
- First Posted Date
- 2013-11-29
- Last Posted Date
- 2020-01-23
- Lead Sponsor
- Mirror Biologics, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT01998542
- Locations
- 🇹🇭
National Cancer Institute of Thailand, Bangkok, Thailand
An Individualized Anti-Cancer Vaccine Study in Patients With HCC
- Conditions
- Hepatocellular Carcinoma
- Interventions
- Biological: AlloVaxBiological: CRCLBiological: AlloStim
- First Posted Date
- 2013-11-26
- Last Posted Date
- 2020-01-22
- Lead Sponsor
- Mirror Biologics, Inc.
- Registration Number
- NCT01995227
- Locations
- 🇮🇱
Hebrew University-Hadassah Medical Center, Jerusalem, Israel